Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorAraujo Castro, Marta
dc.contributor.authorPaja, Miguel
dc.contributor.authorGonzález Boillos, Margarita
dc.contributor.authorPascual-Corrales, Eider
dc.contributor.authorgarcia cano, ana maria
dc.contributor.authorParra Ramírez, Paola
dc.contributor.authorCasteras Román, Anna
dc.contributor.authorPuig Pérez, Albert
dc.date.accessioned2023-08-23T08:02:32Z
dc.date.available2023-08-23T08:02:32Z
dc.date.issued2023-07-07
dc.identifier.citationAraujo-Castro M, Paja Fano M, González Boillos M, Pascual-Corrales E, García Cano AM, Parra Ramírez P, et al. Diagnostic Accuracy of Adrenal Iodine-131 6-Beta-Iodomethyl-19-Norcholesterol Scintigraphy for the Subtyping of Primary Aldosteronism. Biomedicines. 2023 Jul 7;11(7):1934.
dc.identifier.issn2227-9059
dc.identifier.urihttps://hdl.handle.net/11351/10134
dc.descriptionAdrenalectomy; Primary aldosteronism
dc.description.abstractPurpose: To evaluate the diagnostic accuracy of the 131I-6β-iodomethyl-19-norcholesterol (NP-59) adrenal scintigraphy for the subtyping diagnosis of primary aldosteronism (PA), considering as gold standard for the diagnosis of unilateral PA (UPA), either the results of the adrenal venous sampling (AVS) or the outcome after adrenalectomy. Methods: A retrospective multicenter study was performed on PA patients from 14 Spanish tertiary hospitals who underwent NP-59 scintigraphy with an available subtyping diagnosis. Patients were classified as UPA if biochemical cure was achieved after adrenalectomy or/and if an AVS lateralization index > 4 with ACTH stimulation or >2 without ACTH stimulation was observed. Patients were classified as having bilateral PA (BPA) if the AVS lateralization index was ≤4 with ACTH or ≤2 without ACTH stimulation or if there was evidence of bilateral adrenal nodules >1 cm in each adrenal gland detected by CT/MRI. Results: A total of 86 patients with PA were included (70.9% (n = 61) with UPA and 29.1% (n = 25) with BPA). Based on the NP-59 scintigraphy results, 16 patients showed normal suppressed adrenal gland uptake, and in the other 70 cases, PA was considered unilateral in 49 patients (70%) and bilateral in 21 (30%). Based on 59-scintigraphy results, 10.4% of the patients with unilateral uptake had BPA, and 27.3% of the cases with bilateral uptake had UPA. The AUC of the ROC curve of the NP-59 scintigraphy for PA subtyping was 0.812 [0.707–0.916]. Based on the results of the CT/MRI and NP-59 scintigraphy, only 6.7% of the patients with unilateral uptake had BPA, and 24% of the cases with bilateral uptake had UPA. The AUC of the ROC curve of the model combining CT/MRI and 59-scintigraphy results for subtyping PA was 0.869 [0.782–0.957]. Conclusion: The results of NP-59 scintigraphy in association with the information provided by the CT/MRI may be useful for PA subtyping. However, their diagnostic accuracy is only moderate. Therefore, it should be considered a second-line diagnostic tool when AVS is not an option.
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofseriesBiomedicines;11(7)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectHiperaldosteronisme - Diagnòstic
dc.subjectGammagrafia
dc.subjectAldosterona
dc.subject.meshAldosterone
dc.subject.meshHyperaldosteronism
dc.subject.mesh/diagnosis
dc.subject.meshRadionuclide Imaging
dc.titleDiagnostic Accuracy of Adrenal Iodine-131 6-Beta-Iodomethyl-19-Norcholesterol Scintigraphy for the Subtyping of Primary Aldosteronism
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.3390/biomedicines11071934
dc.subject.decsaldosterona
dc.subject.decshiperaldosteronismo
dc.subject.decs/diagnóstico
dc.subject.decsimagen radioisotópica
dc.relation.publishversionhttps://doi.org/10.3390/biomedicines11071934
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Araujo-Castro M] Endocrinology & Nutrition Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. Instituto de Investigación Biomédica Ramón y Cajal (IRYCIS), Madrid, Spain. Medicine Department, University of Alcalá, Madrid, Spain. [Paja Fano M] Endocrinology & Nutrition Department, OSI Bilbao-Basurto, Hospital Universitario de Basurto, Bilbao, Spain. Medicine Department, Basque Country University, Bilbao, Spain. [González Boillos M] Endocrinology & Nutrition Department, Hospital Universitario de Castellón, Castellón, Spain. [Pascual-Corrales E] Endocrinology & Nutrition Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. Instituto de Investigación Biomédica Ramón y Cajal (IRYCIS), Madrid, Spain. [García Cano AM] Biochemistry Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. [Parra Ramírez P] Endocrinology & Nutrition Department, Hospital Universitario La Paz, Madrid, Spain. [Casteràs A, Puig A] Servei d’Endocrinologia i Nutrició, Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid37509573
dc.identifier.wos001034908600001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record